The Guest Editorial by Dr. Allan Flach in the July 2000 issue of Ophthalmology is highly critical of the manner in which ASCRS, ASOA, Dr. Kenneth Rosenthal, and
several tabloids handled the issue of corneal complications attributed to the use
of topical nonsteroidal antiinflammatory drugs (NSAIDs). As a full-time academician
and associate journal editor, I agree with his assertion that the peer-review process
is the ideal (though still imperfect) arbiter of scientific validity. However, as
a clinician and guardian of my patient’s best interests, I believe that it is foolhardy,
impractical, and unethical to always await peer-reviewed reports before intervening
in matters that affect patient safety.
To read this article in full you will need to make a payment
© 2001 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights reserved.